A Single Center, Randomized, Blind, Parallel Controlled, Single Dose Pharmacokinetic Study of Recombinant Humanized Anti-HER-2 Monoclonal Antibody Injection GB221 in Comparison With Herceptin ® in Chinese Healthy Adult Volunteers
Latest Information Update: 25 Sep 2021
At a glance
- Drugs GB 221 (Primary) ; Trastuzumab
- Indications Breast cancer
- Focus Pharmacokinetics
- Sponsors Genor Biopharma
- 02 Jun 2021 New trial record